Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Pubmed

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Download PDF

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Mehta, Shamir R; Tanguay, Jean-Francois; Eikelboom, John W; Jolly, Sanjit S; Joyner, Campbell D; Granger, Christopher B; Faxon, David P; Rupprecht, Hans-Jurgen; Budaj, Andrzej; Avezum, Alvaro; Widimsky, Petr; Steg, Philippe Gabriel; Bassand, Jean-Pierre; Montalescot, Gilles; Macaya, Carlos; Di Pasquale, Giuseppe; Niemela, Kari; Ajani, Andrew E; White, Harvey D; Chrolavicius, Susan; Gao, Peggy; Fox, Keith A A; Yusuf, Salim; ,
The Lancet , Volume 376 (9748): -1189 – Oct 27, 2010

Loading next page...
 
/lp/pubmed/double-dose-versus-standard-dose-clopidogrel-and-high-dose-versus-low-hPykNKvn8v

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0140-6736
DOI
10.1016/S0140-6736(10)61088-4
pmid
20817281

Abstract

Journal

The Lancet – Pubmed

Published: Oct 27, 2010

There are no references for this article.